Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common sites of osteoporosis are the spine, hip and forearm, although it also affects other body parts.
The osteoporosis therapeutic market has become very competitive due to the high number of new drug approvals, although the majority of them are incremental innovations of existing therapies. Competition is fierce, particularly among bisphosphonates and selective estrogen receptor modulators (SERMs), which are mostly used as first-line therapy and dominate the treatment market for osteoporosis patients.
Market Analysis and Insights: Global Osteoporosis Therapeutics Market
The global Osteoporosis Therapeutics market size is projected to reach US$ 10660 million by 2026, from US$ 10420 million in 2020, at a CAGR of 2.2%% during 2021-2026.
Global Osteoporosis Therapeutics Scope and Market Size
Osteoporosis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Osteoporosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
North America
Europe
China
Japan
Southeast Asia
India
The osteoporosis therapeutic market has become very competitive due to the high number of new drug approvals, although the majority of them are incremental innovations of existing therapies. Competition is fierce, particularly among bisphosphonates and selective estrogen receptor modulators (SERMs), which are mostly used as first-line therapy and dominate the treatment market for osteoporosis patients.
Market Analysis and Insights: Global Osteoporosis Therapeutics Market
The global Osteoporosis Therapeutics market size is projected to reach US$ 10660 million by 2026, from US$ 10420 million in 2020, at a CAGR of 2.2%% during 2021-2026.
Global Osteoporosis Therapeutics Scope and Market Size
Osteoporosis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Osteoporosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai
Market segment by Type, the product can be split into
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
